Chorionic Gonadotropin Market 2026–2035 growing with fertility treatment demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Chorionic Gonadotropin Market Over The Period 2026–2030?

The chorionic gonadotropin market has experienced substantial expansion recently. The market is anticipated to expand, reaching $1.43 million in 2026 from $1.34 million in 2025, driven by a compound annual growth rate (CAGR) of 6.5%. Key drivers for this past expansion include an increase in infertility treatments, its established utility in ovulation induction, a rise in male reproductive disorders, the development of hospital-based fertility programs, and its sustained clinical use.

The chorionic gonadotropin market is poised for significant expansion over the next few years, with projections indicating a rise to $1.82 million by 2030, growing at a compound annual growth rate (CAGR) of 6.2%. This growth is primarily fueled by increasing global infertility rates, the proliferation of assisted reproductive technologies, heightened awareness of male hormonal disorders, expanding oncology diagnostic applications, and improved accessibility through retail pharmacies. Furthermore, key trends in the upcoming period encompass a growing utilization in assisted reproductive treatments, an expanding role in male hypogonadism therapy, increasing demand for fertility hormone therapies, extended diagnostic use as a tumor marker, and advancements in formulations and dosage accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

What Drivers Are Expected To Influence The Chorionic Gonadotropin Market During The Forecast Period?

The chorionic gonadotropin market is anticipated to expand due to the escalating incidence of infertility problems. Infertility is defined as the inability for a couple to achieve pregnancy following one year of regular, unprotected sexual activity if they are under 35, or after six months if they are 35 or older. This increase in infertility rates is largely attributed to individuals postponing childbearing until later in life, alongside lifestyle elements such as obesity and smoking that detrimentally affect reproductive health. Chorionic Gonadotropin (hCG) plays a crucial role in fertility therapies by stimulating ovulation in women, aiding the luteal phase for sustaining pregnancy, and boosting testosterone production in men to enhance sperm count, thereby addressing diverse infertility challenges. For example, the World Health Organization (WHO), a specialized agency based in Switzerland, indicated in April 2023 that around 17.5% of the adult global population, equating to 1 in 6 individuals, experiences infertility, highlighting the critical need for better access to affordable, high-quality fertility services for those impacted. Consequently, the growing occurrence of infertility issues is propelling the expansion of the chorionic gonadotropin market.

How Is The Chorionic Gonadotropin Market Divided Into Its Major Segments?

The chorionic gonadotropin market covered in this report is segmented –

1) By Type: Human Chorionic Gonadotropin, Animal Chorionic Gonadotropin

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Therapeutic Application: Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain, Other Therapeutic Applications

4) By End User: Research Institutions, Pharmaceutical Companies

How Are Trends Transforming The Chorionic Gonadotropin Market Landscape?

Leading companies within the chorionic gonadotropin market are prioritizing the development of innovative solutions, such as saliva-based pregnancy tests, to enhance convenience, accuracy, and accessibility. A saliva-based pregnancy test is characterized as a non-invasive diagnostic technique designed to detect pregnancy by analyzing a woman’s saliva for the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. For example, in June 2023, Salignostics, an Israel-based biotech company, introduced what became known as the world’s first saliva-based pregnancy test. This pioneering product allows women to determine pregnancy using a saliva sample instead of urine, identifying the hCG (human chorionic gonadotropin) hormone with results delivered in just 5 to 15 minutes. Salistick offers a more comfortable and user-friendly testing experience, making it possible for individuals to test anywhere and share the moment with partners or loved ones.

Who Are The Prominent Organizations Shaping The Chorionic Gonadotropin Market?

Major companies operating in the chorionic gonadotropin market are Ferring Pharmaceuticals

Read the full chorionic gonadotropin market report here:

https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

Which Region Is Forecast To Lead The Chorionic Gonadotropin Market In Terms Of Market Size?

North America was the largest region in the chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chorionic Gonadotropin Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19888&type=smp

Browse Through More Reports Similar to the Global Chorionic Gonadotropin Market 2026, By The Business Research Company

Human Chorionic Gonadotropin Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Gonadotropin Releasing Hormone Gnrh Agonist Market Report 2026

https://www.thebusinessresearchcompany.com/report/gonadotropin-releasing-hormone-gnrh-agonist-global-market-report

Male Hypogonadism Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795